FIGURE 1.
Progression‐free survival in patients with advanced solid tumors treated with cancer peptide vaccine TAS0313 in the phase I portion of the study, according to lymphocyte count (full analysis set)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.